Advertising
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »
PAST TOP PICK

(A Top Pick March 23/16. Up 9%.) Does clinical trials for the major drug producers, which is about 75% of their business. It’s been mildly disappointing. A very good company. They are growing their cash, which may lead to a dividend being paid in the near future. Very active in buying back shares. It has lots of potential.

biotechnology / pharmaceutical
TOP PICK

A contract research organization that basically takes outsourced clinical studies on behalf of pharmaceuticals, runs the studies through various phases on behalf of them. They have $5.4 billion of backlog. Have just gone through a restructuring process which will be additive in the last half of this year to their earnings.

biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick April 27/11. Down 2.73%.) Contract research for Pharma companies. Very good company. Now going into partnership with large pharmas.
biotechnology / pharmaceutical
PAST TOP PICK
(Top Pick Apr 27/11, Down 5.79%) Clinical trial company. It is an efficient model
biotechnology / pharmaceutical
TOP PICK
Clinical trial management. They take phase 1 drugs and run them through the trials. About a $2.9 billion backlog and a book to bill of about $1.5 billion, meaning that for every $1 they bill, they get orders of $1.50.
biotechnology / pharmaceutical
PAST TOP PICK
(A Top Pick March 11/09. Up 180.8%.) About 60% of revenues come from outside the US.
biotechnology / pharmaceutical
PAST TOP PICK
(Top Pick Mar 11/09, Up 163.6%) Not as cheap as it was, but still good value.
biotechnology / pharmaceutical
TOP PICK
Contract research organization and do drug trials on behalf of pharmaceuticals and biopharmas. Stock has been beaten down on worries of lack of pipeline and foreign exchange worries.
biotechnology / pharmaceutical
TOP PICK
Contract research that does clinical drug trials for major drug companies. Strong growing franchise.
biotechnology / pharmaceutical
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »

Parexel International Corp.(PRXL-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Parexel International Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Parexel International Corp.(PRXL-Q) Frequently Asked Questions

What is Parexel International Corp. stock symbol?

Parexel International Corp. is a OTC stock, trading under the symbol PRXL-Q on the (). It is usually referred to as or PRXL-Q

Is Parexel International Corp. a buy or a sell?

In the last year, there was no coverage of Parexel International Corp. published on Stockchase.

Is Parexel International Corp. a good investment or a top pick?

Parexel International Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Parexel International Corp..

Why is Parexel International Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Parexel International Corp. worth watching?

In the last year, there was no coverage of Parexel International Corp. published on Stockchase.

What is Parexel International Corp. stock price?

On , Parexel International Corp. (PRXL-Q) stock closed at a price of $.